tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Stock Investors

216 Followers
Based on 744,106 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LTRN
On average, investors allocate 0.00% of their portfolios to LTRN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 744,106 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LTRN

1.8%
Last 7
Days
9.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LTRN, out of 744,106 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LTRN Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
72.18%
$4.15
Based on the activity of 14,093 investors who made their portfolios public
The table shows changes in LTRN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LTRN Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.10%
-1.19%
-2.23%
706.00M
Consumer Cyclical
Bristol-Myers Squibb
3.19%
+0.15%
+1.35%
81.21B
Healthcare
Airbnb
4.51%
+2.05%
+1.97%
98.36B
Consumer Cyclical
Marathon Digital Holdings
5.64%
-0.20%
-1.12%
5.73B
Financial
Merck & Company
3.92%
+0.11%
+3.25%
318.75B
Healthcare
DraftKings
5.76%
-0.93%
-1.61%
32.86B
Consumer Cyclical
Applied Materials
4.72%
+0.59%
+5.14%
201.45B
Technology
Raytheon Technologies
4.00%
-0.22%
-1.47%
133.93B
Industrials
Block
4.18%
+0.03%
-0.06%
39.76B
Technology
Citigroup
4.99%
-0.63%
+0.14%
122.95B
Financial
Based on the activity of 744,106 active portfolios
Open your Smart Portfolio

LTRN Investor Analysis

LTRN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.0%
of LTRN holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
LTRN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of LTRN holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
LTRN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.0%
of LTRN holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of LTRN stock investors
See who invests in LTRN according to age group and performance.

FAQ

How many retail Investors hold LTRN?
<0.1% of TipRanks' retail investors hold LTRN in their portfolios.
    What is LTRN Investor Sentiment?
    LTRN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of LTRN in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of LTRN in the last 7 days.
        What percentage of retail investors changed their holding of LTRN in the last 30 days?
        ▼ 9.8% of TipRanks' retail investors changed their holding of LTRN in the last 30 days.
          What is the average age of retail investors who hold LTRN?
          The average age of LTRN Holders is between 35–55.
            What other stocks have LTRN investors also bought?
            LTRN Investors also bought CHPT, BMY, ABNB, MARA, MRK, DKNG, AMAT, RTX, SQ, C.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AZNAstraZeneca
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              INSMInsmed
              LGNDLigand Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis